Kennedy Challenges Trump’s Drug Price Claims at Senate Hearing
U.S. Health Secretary Robert F. Kennedy Jr.
presented a critical assessment of President Donald Trump’s claims concerning prescription drug price reductions during a Senate Finance Committee hearing yesterday. Kennedy addressed discrepancies between Trump’s assertions and established mathematical calculations regarding the “TrumpRx” platform. The platform, designed to offer Americans discounts on branded drugs, has been promoted by the Trump administration.
Kennedy explained that when President Trump references a drug price decreasing from $600 to $10, he frames this as a “600 percent reduction.”
During the hearing, Kennedy calmly detailed the underlying logic, asserting that the president employs a different method for calculating percentage reductions. He clarified that the Trump administration views the “TrumpRx” initiative as a successful government service. The exchange occurred with Robert F.
Kennedy Jr. – often referred to as kennedy – presenting a counterpoint to the president’s publicly stated figures. The discussion centered on the accuracy of reporting on the impact of the TrumpRx program.
The hearing involved both kennedy and trump, focusing on the presentation of data related to prescription drug costs.
Topics: #trump #kennedy #health
